Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing–remitting multiple sclerosis?

Overview of attention for article published in Neuropsychiatric Disease and Treatment, October 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

blogs: 1 blog
twitter: 1 X user
facebook: 1 Facebook page

googleplus: 1 Google+ user
video: 1 YouTube creator

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 20 Mendeley

Summary Blogs X Facebook Google+ YouTube Dimensions citations

So far, Altmetric has seen 1 Google+ post.

Dove Medical Press (NZ) Ltd, 25 Oct 2012

Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing–remitting... Can a…